Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAP2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | OGG1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | RBSN | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ADAM10 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ARHGEF35 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | FLRT3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | C1orf109 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | CD58 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |